Why Transcat Stock Is Up Big Today
![https://store.livarava.com/51cfedcb-178c-11ef-a6c7-63e1980711b2.jpg](https://store.livarava.com/51cfedcb-178c-11ef-a6c7-63e1980711b2.jpg)
Strong Earnings and Margin Growth
The testing and calibration company, Transcat (NASDAQ: TRNS), surpassed Wall Street's estimates, reporting earnings of $0.66 per share on revenue of $70.9 million in its fiscal fourth quarter. The company experienced a 29.8% growth in consolidated adjusted EBITDA, paired with a 200 basis points expansion in EBITDA margin.
Is Transcat a Buy?
CEO Lee D. Rudow foresees continued growth in 2025 from recurring revenue streams in regulated sectors like life sciences. The company's diversification and focus on higher-margin business segments position it well against economic uncertainties.
Investing Consideration
- Transcat is serving vital industries with room for growth.
- The company's execution and expansion could lead to further stock gains.
- Considerations against popular analyst recommendations for long-term potential.